INSIGHTS B — STAGING

In 2003, David Sinclair published a paper showing that resveratrol activated sirtuins and extended lifespan in yeast. The world went insane. Red wine sales spiked. Supplement companies printed money. GlaxoSmithKline dropped $720 million on a resveratrol startup. Two decades later, the molecule's report card is a lot more complicated than anyone expected.